메뉴 건너뛰기




Volumn 94, Issue 6, 2014, Pages 715-717

The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CALCIUM; CYCLOSPORIN; ETANERCEPT; ETRETIN; PARATHYROID HORMONE; VITAMIN D; BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT; PTH PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

EID: 84907986121     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1801     Document Type: Article
Times cited : (14)

References (18)
  • 2
    • 79952148734 scopus 로고    scopus 로고
    • Clinical practice. Vitamin D insufficiency
    • Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011; 364: 248-254.
    • (2011) N Engl J Med , vol.364 , pp. 248-254
    • Rosen, C.J.1
  • 6
    • 84863335934 scopus 로고    scopus 로고
    • Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis
    • Campanati A, Orciani M, Gorbi S, Regoli F, Di Primio R, Offidani A. Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis. Br J Dermatol 2012; 167: 68-76.
    • (2012) Br J Dermatol , vol.167 , pp. 68-76
    • Campanati, A.1    Orciani, M.2    Gorbi, S.3    Regoli, F.4    Di Primio, R.5    Offidani, A.6
  • 8
    • 21344463548 scopus 로고    scopus 로고
    • Benefits and requirements of vitamin D for optimal health: A review
    • Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: A review. Alt Med Rev 2005; 10: 94-111.
    • (2005) Alt Med Rev , vol.10 , pp. 94-111
    • Grant, W.B.1    Holick, M.F.2
  • 11
    • 84880798525 scopus 로고    scopus 로고
    • The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis
    • Campanati A, Ganzetti G, Di Sario A, Damiani A, Sandroni L, Rosa L, Benedetti A, Offidani A. The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. J Gastroenterol 2013; 48: 839-846.
    • (2013) J Gastroenterol , vol.48 , pp. 839-846
    • Campanati, A.1    Ganzetti, G.2    Di Sario, A.3    Damiani, A.4    Sandroni, L.5    Rosa, L.6    Benedetti, A.7    Offidani, A.8
  • 12
    • 84865093412 scopus 로고    scopus 로고
    • Psodisk a new visual method for assessing the burden of psoriasis on patients
    • Linder D, Sampogna F, Torreggiani A, Balato N, Bianchi L, Cassano N, et al. Psodisk a new visual method for assessing the burden of psoriasis on patients. JEADV 2011; 26: 1163-1166.
    • (2011) JEADV , vol.26 , pp. 1163-1166
    • Linder, D.1    Sampogna, F.2    Torreggiani, A.3    Balato, N.4    Bianchi, L.5    Cassano, N.6
  • 15
    • 84865801700 scopus 로고    scopus 로고
    • Alopecia Areata: A possible extraintestinal manifestation of Crohn's disease
    • Ganzetti G, Campanati A, Offidani A. Alopecia Areata: a possible extraintestinal manifestation of Crohn's disease. J Crohns Colitis 2012; 6: 962-963
    • (2012) J Crohns Colitis , vol.6 , pp. 962-963
    • Ganzetti, G.1    Campanati, A.2    Offidani, A.3
  • 16
    • 84862492669 scopus 로고    scopus 로고
    • Infection of RANKL-primed RAW-D macrophages with porphyromonas gingivalis promotes osteoclastogenesis in a TNF-alpha independent manner
    • Kukita A, Ichigi Y, Takigawa I, Watanabe T, Kukita T, Miyamoto H. Infection of RANKL-primed RAW-D macrophages with porphyromonas gingivalis promotes osteoclastogenesis in a TNF-alpha independent manner. PLoS One 2012; 7: 1-12.
    • (2012) PLoS One , vol.7 , pp. 1-12
    • Kukita, A.1    Ichigi, Y.2    Takigawa, I.3    Watanabe, T.4    Kukita, T.5    Miyamoto, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.